Glaxosmithkline Pharmaceuticals informs about issue of duplicate share certificates

29 Sep 2023 Evaluate
Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Glaxosmithkline Pharmaceuticals has informed that Registrar and Transfer Agent of Company KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2584.35 -40.50 (-1.54%)
27-Feb-2026 14:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1759.60
Dr. Reddys Lab 1291.45
Cipla 1349.00
Zydus Lifesciences 925.20
Lupin 2316.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×